TMEM229A suppresses nonsmall cell lung cancer progression via inactivating the ERK pathway. Zhang X, He Y, Jiang Y, Bao Y, et al. Oncol Rep 2021;46.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhang X, He Y, Jiang Y, Bao Y, et al. TMEM229A suppresses nonsmall cell lung cancer progression via inactivating the ERK pathway. Oncol Rep 2021;46.
PMID: 34184076